| Jul 8 |
Gilead Sciences upgraded to Outperform by Raymond James
|
| Jul 3 |
5 FDA decisions to watch in the third quarter
|
| Jul 2 |
Should You Be Concerned About Gilead Sciences, Inc.'s (NASDAQ:GILD) ROE?
|
| Jul 2 |
Insider Sale: Chief Medical Officer Merdad Parsey Sells Shares of Gilead Sciences Inc (GILD)
|
| Jul 1 |
Gilead Benefit Helps Employees Navigate Cancer Care
|
| Jul 1 |
Should You Hold Gilead Sciences (GILD)?
|
| Jul 1 |
3 Magnificent Stocks Retirees Can Buy and Hold Forever
|
| Jun 26 |
Recent uptick might appease Gilead Sciences, Inc. (NASDAQ:GILD) institutional owners after losing 4.6% over the past year
|
| Jun 25 |
Gilead Sciences (GILD) Stock Sinks As Market Gains: What You Should Know
|
| Jun 24 |
Gilead Sciences: Strategic Gains From Lenacapavir And Trodelvy Justify A Buy Rating
|
